ArborMed is a biopharmaceutical company committed to the development and commercialization of therapeutics for diseases with high unmet medical needs and untapped market opportunities.
With operations in South Korea and US, Arbormed utilizes resources efficiently to enable "Fast to Market" development of the pipeline and US market entry.
Our Demand-Driven Development (D³) approach incorporates 3 strategic pillars to build a risk-balanced pipeline:
▶Innovative new drug - starting from mid preclinical stage, develop best in class therapies with validated targets with a particular focus on rare diseases.
▶Complex generics - commercialize complex generic products with limited competition in the US that have been developed by Korean companies.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 7th Fl.,12, Nonhyeon-Ro 81-Gil, Gangnam-Gu,seoul 06237,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- arbormed.com
- Keywords
- Rare disease and Orphan drug.
- HQ
- Gangnam-gu, Seoul
Arbormed Questions
Arbormed's website is arbormed.com
Arbormed's LinkedIn profile is https://www.linkedin.com/company/arbormed
Arbormed has
13 employees.
View email and phone details for 13
employees at Arbormed.
Arbormed's industry is
Pharmaceutical Manufacturing
Arbormed's top competitors are
Pals Chrysalis Health,
Key Proteo, Inc.,
Quality Control Manufacturing,
Balance Innovation Center, Llc,
Prime Medicine, Inc.,
Scribex,
Baks Medical,
Praanatech,
Therabest,
Lifemax Laboratories, Inc..
Arbormed's categories are Pharmaceutical Manufacturing
Arbormed's founding year is 2017
